Join the first CRE RESPOND OPAT/HITH Masterclass for 2023 to hear expert clinicians and clinical educators discuss Optimised Dosing Decisions, including perspectives on use of antimicrobial therapeutic drug monitoring (TDM) for paediatric patients; dosing of meropenem in OPAT, challenges and successes of endocarditis in OPAT; and for who, when, where Oritavancin should be used. We look forward to an interesting discussion – join us to ask our panel about your experiences.
CRE RESPOND offers light dinner to those attending in person at the RBWH Education Centre, Herston, QLD from 5.30pm. Zoom link will be provided to those attending the seminar online.
